Faculty Profiles

Elaine Ku, MD
M_MED-NEPH-CORE-GEN
Assistant Professor

533 Parnassus Avenue
San Francisco, CA 94117
415-476-3546
Elaine.Ku@ucsf.edu

EDUCATION
College: University of California Los Angeles, BS
Medical School: University of California San Diego, MD
Medicine-Pediatrics Residency: University of Southern California
Adult and Pediatric Nephrology Fellowship: University of California San Francisco
Other Graduate Training: University of California San Francisco, MAS



INTERESTS
Dr. Ku's research focuses primarily on hypertension and its long-term sequelae in populations at high cardiovascular risk (chronic kidney disease and diabetes). In addition, Dr. Ku is also interested in understanding the optimal approach to the care of young patients with pediatric-onset chronic kidney disease as they transition into adulthood.

Interests

Cardiovascular risk factors in chronic kidney disease, Hypertension, Transitional care

Awards and Honors
2016   National Kidney Foundation, Satellite Dialysis Clinical Investigator Grant, 2016-2018
2013   American Kidney Fund, Clinical Scientist in Nephrology Award, 2013-2014

Awarded Grants

Project Title Project Number Fiscal Year
Blood pressure trends, outcomes, and interventions in adolescents and young adults at increased cardiovascular risk K23HL131023 2021
Role of pre-ESRD blood pressure management on post-ESRD outcomes F32DK098871 2016
Recent Articles (24)

Ku E, Bakris G, Johansen KL, Lin F, Sarnak MJ, Campese VM, Jamerson K, Gassman JJ, Smogorzewski M, Hsu CY. Acute Declines in Renal Function during Intensive BP Lowering: Implications for Future ESRD Risk. J Am Soc Nephrol. 2017 May 04.

Ku E, McCulloch CE, Grimes BA, Johansen KL. Racial and Ethnic Disparities in Survival of Children with ESRD. J Am Soc Nephrol. 2016 Dec 29.

Ku E, Lipkowitz MS, Appel LJ, Parsa A, Gassman J, Glidden DV, Smogorzewski M, Hsu CY. Strict blood pressure control associates with decreased mortality risk by APOL1 genotype. Kidney Int. 2016 Dec 04.

Ku E, McCulloch CE, Mauer M, Gitelman SE, Grimes BA, Hsu CY. Association Between Blood Pressure and Adverse Renal Events in Type 1 Diabetes. Diabetes Care. 2016 Dec; 39(12):2218-2224.

Ku E, Gassman J, Appel LJ, Smogorzewski M, Sarnak MJ, Glidden DV, Bakris G, GutiƩrrez OM, Hebert LA, Ix JH, Lea J, Lipkowitz MS, Norris K, Ploth D, Pogue VA, Rostand SG, Siew ED, Sika M, Tisher CC, Toto R, Wright JT, Wyatt C, Hsu CY. BP Control and Long-Term Risk of ESRD and Mortality. J Am Soc Nephrol. 2016 Aug 11.

Ku E, Fine RN, Hsu CY, McCulloch C, Glidden DV, Grimes B, Johansen KL. Height at First RRT and Mortality in Children. Clin J Am Soc Nephrol. 2016 May 6; 11(5):832-9.

Ku E, Xie D, Shlipak M, Hyre Anderson A, Chen J, Go AS, He J, Horwitz EJ, Rahman M, Ricardo AC, Sondheimer JH, Townsend RR, Hsu CY. Change in Measured GFR Versus eGFR and CKD Outcomes. J Am Soc Nephrol. 2016 Jul; 27(7):2196-204.

Ku E, Glidden DV, Hsu CY, Portale AA, Grimes B, Johansen KL. Association of Body Mass Index with Patient-Centered Outcomes in Children with ESRD. J Am Soc Nephrol. 2016 Feb; 27(2):551-8.

Ku E, Johansen KL, Portale AA, Grimes B, Hsu CY. State level variations in nephrology workforce and timing and incidence of dialysis in the United States among children and adults: a retrospective cohort study. BMC Nephrol. 2015; 16:2.

Ku E, Glidden DV, Johansen KL, Sarnak M, Tighiouart H, Grimes B, Hsu CY. Association between strict blood pressure control during chronic kidney disease and lower mortality after onset of end-stage renal disease. Kidney Int. 2015 May; 87(5):1055-60.

Ku E, Thomas M, Ho CH, Whipple NS, Abdul-Rahman O, Megason GC, Herrington BL, Carmody JB, Charlton JR. Index of suspicion. Case 1: fever, diarrhea, jaundice, and confusion in an 18-year-old male. Case 2: severe anemia in a 6-month-old girl. Case 3: red urine in a 4-month-old boy. Pediatr Rev. 2014 Mar; 35(3):129-35.

Hsu RK, McCulloch CE, Ku E, Dudley RA, Hsu CY. Regional variation in the incidence of dialysis-requiring AKI in the United States. Clin J Am Soc Nephrol. 2013 Sep; 8(9):1476-81.

Ku E, Campese V. Is lipid management effective for all stages of CKD?. Blood Purif. 2013; 35(1-3):26-30.

Ku E, Ananthapanyasut W, Campese VM. IgA nephropathy in a patient with ulcerative colitis, Graves' disease and positive myeloperoxidase ANCA. Clin Nephrol. 2012 Feb; 77(2):146-50.

Campese VM, Ku E, Bigazzi R, Bianchi S. Do HMG-CoA reductase inhibitors improve kidney function? The saga continues. J Nephrol. 2011 Sep-Oct; 24(5):550-3.

Campese VM, Ku E, Park J. Sympathetic renal innervation and resistant hypertension. Int J Hypertens. 2011; 2011:814354.

Ku E, Brotherton BJ, Parrish C, Zia SK, McKenna S. Visual diagnosis: vaginal mass in a 16-month-old child. Pediatr Rev. 2010 Aug; 31(8):337-40.

Lu Y, Ku E, Campese VM. Aldosterone in the pathogenesis of chronic kidney disease and proteinuria. Curr Hypertens Rep. 2010 Aug; 12(4):303-6.

Ku E, Campese VM. Aldosterone and hypertension in African Americans. Am J Hypertens. 2009 Dec; 22(12):1234.

Ku E, Cheung EL, Khan A, Yu AS. Anion and osmolal gaps after alcohol intoxication. Am J Kidney Dis. 2009 Aug; 54(2):385-8.

Ku E, Park J, Vidhun J, Campese V. The hazards of dual renin-angiotensin blockade in chronic kidney disease. Arch Intern Med. 2009 Jun 8; 169(11):1015-8.

Ku E, Nobakht N, Campese VM. Lixivaptan: a novel vasopressin receptor antagonist. Expert Opin Investig Drugs. 2009 May; 18(5):657-62.

Ku E, Campese VM. Role of aldosterone in the progression of chronic kidney disease and potential use of aldosterone blockade in children. Pediatr Nephrol. 2009 Dec; 24(12):2301-7.

  Select data provided by UCSF Profiles, powered by CTSI at UCSF. Learn more about the data source.